Pluri Inc. — Director's Dealing 2025

May 20, 2025

Form_13D/A false

����� ����	2 380
PLURI INC
Corporation no: C12337-2001	15574
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	20/05/2025
	www.isa.gov.il			www.tase.co.il				Reference:	2025-02-035417	Time of broadcast: 15:18 15:18

---

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onForm_13D/A

ea024280901-13da1yanay_pluriEDGAR_As_Filed_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 06/08/2024
Address: Matam Park 5 , Haifa 31905   ISRAEL , Tel: 074-7107171 , Fax: 074-7107172
E-mail address: Info@Pluristem.Com   Company site: www.pluristem.com
Previous names of reporting entity: PLURISTEM THERAPEUTICS INC
Name of the Signatory: Zalts Zelig Liat Position of Signatory in the reporting corporation: CFO, Senior Vice president & Treasurer Name of Employer Company:
Address: Matam Park 5 , Haifa 3190500 Telephone: 074-7108600 Facsimile: E-mail: liat.zalts@pluri-biotech.com 1